Increased anti-Echinococcus granulosus antibody positivity in Fasciola hepatica infection

Basit Öğe Kaydı
dc.contributor.authorKaya, Muhsin
dc.contributor.authorBestas, Remzi
dc.contributor.authorGirgin, Sadullah
dc.contributor.authorCicek, Muttalip
dc.contributor.authorKaplan, Mehmet Ali
dc.date.accessioned2024-04-24T17:24:36Z
dc.date.available2024-04-24T17:24:36Z
dc.date.issued2012
dc.departmentDicle Üniversitesien_US
dc.description.abstractBackground/aims: Parasitic helminths express some antigen, which often accounts for serological cross-reactions. The aim of this study was to determine the prevalence of anti- Echinococcus granulosus antibody in patients with Fasciola hepatica infection using indirect immunofluorescence assay. Materials and Methods: The study population consisted of the following groups: Fasciola hepatica group (n=22), hydatid disease group (n=22) and healthy control group (n=24). Indirect immunofluorescence assay for Echinococcus granulosus was performed in all groups. Results: Indirect immunofluorescence assay was positive in all patients with hydatid disease, in 13 of 22 (59%) patients with fascioliasis and in 2 of 24 (8%) healthy subjects. The positivity rate of indirect immunofluorescence assay was significantly higher in the hydatid disease group compared to the fascioliasis group (p<0.001) and compared to the control group (p<0.001), and it was significantly higher in the fascioliasis group compared to the control group (p=0.001). Antibody titer was 11100 in 7 patients, 11320 in 12 patients and 111000 in 3 patients with hydatid disease. Indirect immunofluorescence assay was positive in 10 of 15 patients with hepatic phase and in 3 of 7 patients with biliary phase of fascioliasis. The antibody titer was 11100 in 6 and 11320 in 7 patients with fascioliasis. The antibody titer was 11100 in both healthy subjects. Conclusions: Indirect immunofluorescence assay for Echinococcus granulosus may be positive in a majority of patients with Fasciola hepatica infection and in some healthy subjects.en_US
dc.identifier.doi10.4318/tjg.2012.0354
dc.identifier.endpage343en_US
dc.identifier.issn1300-4948
dc.identifier.issn2148-5607
dc.identifier.issue4en_US
dc.identifier.pmid22965504
dc.identifier.startpage339en_US
dc.identifier.trdizinid147592
dc.identifier.urihttps://doi.org/10.4318/tjg.2012.0354
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/147592
dc.identifier.urihttps://hdl.handle.net/11468/19754
dc.identifier.volume23en_US
dc.identifier.wosWOS:000309026000004
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherAvesen_US
dc.relation.ispartofTurkish Journal of Gastroenterology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectFasciola Hepaticaen_US
dc.subjectEchinococcus Granulosusen_US
dc.subjectIndirect Immunofluorescence Assayen_US
dc.titleIncreased anti-Echinococcus granulosus antibody positivity in Fasciola hepatica infectionen_US
dc.titleIncreased anti-Echinococcus granulosus antibody positivity in Fasciola hepatica infection
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu